Bristol Myers Squibb and Exelixis have a potential kidney cancer contender on their hands—but they’ll have to meet a “high bar” to gain traction in the crowded field...

Novartis is looking to grow its new multiple sclerosis drug Mayzent in a crowded field, and, with Gilenya generics threatening, the newer MS medicine may need to car...

As of this morning – Thursday April 16 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 98,476 with 12,868 deaths. More than 20 inter...

Gedeon Richter has launched its new hormone replace therapy (HRT) Lenzetto (estradiol spray) in the UK, offering post-menopausal women an alternative treatment optio...

Cambridge, UK-based Healx has formed a new partnership with US and Europe-based patient group the Children’s Tumor Foundation (CTF) to progress new AI-derived therap...

With pharmaceutical supply chains under immense pressure due to the novel coronavirus, China's role as a global ingredient producer has come under scrutiny. Despite ...

Aside from its devastating health consequences, the COVID-19 pandemic has left millions of Americans without work—and therefore without health insurance. Now, two Bi...

Roche has stepped on the gas in testing Actemra for coronavirus patients, thanks to a little more help from the U.S. government. With $25 million in backing from t...